Accessibility: Skip TopNav
Jacques Turgeon, BPharm, PhD, TRHC Chief Scientific Officer and CEO
TRHC Scientific Precision Pharmacotherapy Research & Development Institute
Format
JPEG
Source
Tabula Rasa HealthCare, Inc.
Downloads
Original
Large
Medium
Small